341 related articles for article (PubMed ID: 19629933)
1. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy.
Kiyici S; Ersoy C; Oz Gul O; Sarandol E; Demirci M; Tuncel E; Sigirli D; Erturk E; Imamoglu S
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):386-90. PubMed ID: 19629933
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
3. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.
English PJ; Ashcroft A; Patterson M; Dovey TM; Halford JC; Harrison J; Eccleston D; Bloom SR; Ghatei MA; Wilding JP
Diabetes Metab Res Rev; 2007 May; 23(4):299-303. PubMed ID: 16952199
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
[TBL] [Abstract][Full Text] [Related]
5. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
Intern Med J; 2007 Feb; 37(2):79-86. PubMed ID: 17229249
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
8. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
10. Treatment with pioglitazone is associated with decreased preprandial ghrelin levels: a randomized clinical trial.
Taslimi S; Esteghamati A; Rashidi A; Tavakkoli HM; Nakhjavani M; Kebriaee-Zadeh A
Peptides; 2013 Feb; 40():89-92. PubMed ID: 23276779
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.
Strowig SM; Raskin P
Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007
[TBL] [Abstract][Full Text] [Related]
13. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
Garcia AL; Otto B; Reich SC; Weickert MO; Steiniger J; Machowetz A; Rudovich NN; Möhlig M; Katz N; Speth M; Meuser F; Doerfer J; Zunft HJ; Pfeiffer AH; Koebnick C
Eur J Clin Nutr; 2007 Mar; 61(3):334-41. PubMed ID: 16988651
[TBL] [Abstract][Full Text] [Related]
14. A fixed-dose combination of pioglitazone and metformin: A promising alternative in metabolic control.
Seufert J
Curr Med Res Opin; 2006; 22 Suppl 2():S39-48. PubMed ID: 16914074
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
Mori K; Emoto M; Araki T; Yokoyama H; Lee E; Teramura M; Koyama H; Shoji T; Inaba M; Nishizawa Y
Metabolism; 2008 Sep; 57(9):1248-52. PubMed ID: 18702951
[TBL] [Abstract][Full Text] [Related]
18. Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: a possible role in weight stability?
Kusaka I; Nagasaka S; Horie H; Ishibashi S
Diabetes Obes Metab; 2008 Nov; 10(11):1039-46. PubMed ID: 18355332
[TBL] [Abstract][Full Text] [Related]
19. Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes.
Sambanis C; Tziomalos K; Kountana E; Kakavas N; Zografou I; Balaska A; Koulas G; Karagiannis A; Zamboulis C
Acta Diabetol; 2008 Mar; 45(1):23-30. PubMed ID: 17768592
[TBL] [Abstract][Full Text] [Related]
20. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
Emral R; Köseoğlulari O; Tonyukuk V; Uysal AR; Kamel N; Corapçioğlu D
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]